Vistakon Pharmaceuticals Llc
Manufacturer Details
There are currently no manufacturer details available.
Vistakon Pharmaceuticals Llc Drugs
-
![Alamast (Pemirolast Potassium) Solution [Vistakon Pharmaceuticals Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=18836374-7e66-45bd-8380-3f9714de0b40&name=alamast-02.jpg)
Alamast
The recommended dose is one to two drops in each affected eye four times daily.
Symptomatic response to therapy (decreased itching) may be evident within a few days, but frequently requires longer treatment (up to four weeks).
-
![Iquix (Levofloxacin) Solution [Vistakon Pharmaceuticals Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=067ea8ec-99a3-4a0b-9116-4ffd6160b24b&name=iquix-02.jpg)
Iquix
Days 1 through 3
Instill one to two drops in the affected eye(s) every 30 minutes to 2 hours while awake and approximately 4 and 6 hours after retiring.
Day 4 through treatment completion
Instill one to two drops in the affected eye(s) every 1 to 4 hours while awake.
-
![Betimol (Timolol) Solution [Vistakon Pharmaceuticals Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=00f62dd1-dad2-4892-8a5d-21e5e54509ce&name=betimol-02.jpg)
Betimol
Betimol® Ophthalmic Solution is available in concentrations of 0.25 and 0.5 percent. The usual starting dose is one drop of 0.25 percent Betimol® in the affected eye(s) twice a day. If the clinical response is not adequate, the dosage may be changed to one drop of 0.5 percent solution in the affected eye(s) twice a day.
If the intraocular pressure is maintained at satisfactory levels, the dosage schedule may be changed to one drop once a day in the affected eye(s). Because of diurnal variations in intraocular pressure, satisfactory response to the once-a-day dose is best determined by measuring the intraocular pressure at different times during the day.
Since in some patients the pressure-lowering response to Betimol® may require a few weeks to stabilize, evaluation should include a determination of intraocular pressure after approximately 4 weeks of treatment with Betimol® .
Dosages above one drop of 0.5 percent Betimol® twice a day generally have not been shown to produce further reduction in intraocular pressure. If the patient's intraocular pressure is still not at a satisfactory level on this regimen, concomitant therapy with pilocarpine and other miotics, and/or epinephrine, and/or systemically administered carbonic anhydrase inhibitors, such as acetazolamide, can be instituted.
-
![Quixin (Levofloxacin) Solution [Vistakon Pharmaceuticals Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=09b3a912-97f9-45ae-a162-9f45c860dc22&name=quixin-02.jpg)
Quixin
Sign Up for a Free Account